Elefante Mark B’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.71M Buy
4,031
+1,133
+39% +$1.15M 2.04% 23
2025
Q4
$3.11M Buy
2,898
+726
+33% +$694K 1.91% 23
2025
Q3
$1.66M Buy
2,172
+855
+65% +$636K 1.06% 29
2025
Q2
$1.03M Buy
1,317
+729
+124% +$566K 0.77% 31
2025
Q1
$486K Buy
+588
New +$489K 0.38% 39

Other funds holding LLY

Elefante Mark B's LLY Position: Q1 2026 in Review

Elefante Mark B increased its Eli Lilly (LLY) stake by 39% in Q1 2026, buying an estimated $1.15M and bringing the position to 4,031 shares worth $3.71M. The position accounts for 2.04% of the portfolio, ranked #23.

Elefante Mark B first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Elefante Mark B held 4,031 shares of Eli Lilly worth $3.71M as of Q1 2026.
  • Elefante Mark B bought 1,133 Eli Lilly shares in Q1 2026, an estimated $1.15M.
  • Eli Lilly made up 2.04% of Elefante Mark B's portfolio in Q1 2026, its #23 holding.
  • Elefante Mark B first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Elefante Mark B's 13F filing for Q1 2026, filed 15 May 2026.